Invion and Hudson Institute of Medical Research are collaborating on R&D projects for the PhotosoftTM technology as a treatment of a range of cancers PhotosoftTM characterisation studies have been completed in multiple ovarian cancer cell lines PhotosoftTM caused efficient and highly effective cancer cell destruction in vitro Melbourne, Australia, 5 July 2018: Invion Limited (ASX:…
Read more
